Pexip Infinity up to 34.0 Waiting Room access control

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
5.3$0-$5k0.00

Summaryinfo

A vulnerability categorized as critical has been discovered in Pexip Infinity up to 34.0. This issue affects some unknown processing of the component Waiting Room Handler. The manipulation results in access control. This vulnerability is cataloged as CVE-2024-33850. There is no exploit available. It is advisable to upgrade the affected component.

Detailsinfo

A vulnerability, which was classified as critical, was found in Pexip Infinity up to 34.0. Affected is an unknown functionality of the component Waiting Room Handler. The manipulation with an unknown input leads to a access control vulnerability. CWE is classifying the issue as CWE-284. The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor. This is going to have an impact on confidentiality, integrity, and availability. CVE summarizes:

Pexip Infinity before 34.1 has Improper Access Control for persons in a waiting room. They can see the conference roster list, and perform certain actions that should not be allowed before they are admitted to the meeting.

The advisory is shared for download at docs.pexip.com. This vulnerability is traded as CVE-2024-33850 since 04/27/2024. The exploitability is told to be easy. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1068.

Upgrading to version 34.1 eliminates this vulnerability.

VulDB is the best source for vulnerability data and more expert information about this specific topic.

Productinfo

Vendor

Name

Version

License

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 5.5
VulDB Meta Temp Score: 5.3

VulDB Base Score: 5.5
VulDB Temp Score: 5.3
VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

Exploitinginfo

Class: Access control
CWE: CWE-284 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍

Physical: No
Local: No
Remote: Partially

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-DayUnlockUnlockUnlockUnlock
TodayUnlockUnlockUnlockUnlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: Upgrade
Status: 🔍

0-Day Time: 🔍

Upgrade: Infinity 34.1

Timelineinfo

04/27/2024 🔍
06/11/2024 +45 days 🔍
06/11/2024 +0 days 🔍
06/11/2024 +0 days 🔍

Sourcesinfo

Advisory: docs.pexip.com
Status: Confirmed

CVE: CVE-2024-33850 (🔍)
GCVE (CVE): GCVE-0-2024-33850
GCVE (VulDB): GCVE-100-267744

Entryinfo

Created: 06/11/2024 07:24
Changes: 06/11/2024 07:24 (54)
Complete: 🔍
Cache ID: 216::103

VulDB is the best source for vulnerability data and more expert information about this specific topic.

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Want to stay up to date on a daily basis?

Enable the mail alert feature now!